MRPL42 Knockdown Suppresses the Malignant Functions of Hepatocellular Carcinoma by Regulating Oxidative Phosphorylation

2026/03/06 by LV Jun, Jun Lv, Fu-yuan Gan +4 · 1 voice
Biochemistry, Genetics and Molecular Biology · Medicine · #Ferroptosis and cancer prognosis #Hepatocellular Carcinoma Treatment and Prognosis #Mitochondrial Function and Pathology

paper · doi:10.1007/s11596-026-00176-x

crossref issued 2026/03/06 · crossref published 2026/03/06 · crossref published-online 2026/03/06 · openalex publication_date 2026/03/06 · crossref created 2026/03/06 · openalex created_date 2026/03/07 · crossref published-print 2026/04/01 · crossref deposited 2026/04/28 · crossref indexed 2026/04/29 · openalex updated_date 2026/08/01

Citations

• Global Epidemiology and Genetics of Hepatocellular Carcinoma
• Predictors of early and late hepatocellular carcinoma recurrence
• Silencing NCAPD3 Inhibits Tumor Growth and Metastasis in Hepatocellular Carcinoma by Suppressing PI3K-AKT Signalling Pathway

Discussions

• This study finds that MRPL42 is overexpressed in #HCC and serves as a diagnostic and prognostic #Biomarker with knockdown suppressing #MalignantProgression via #OXPHOS regulation, positioning MRPL42 a [bsky, 0 points, 0 comments]